Abbott’s HIV immune globulin
Executive Summary
Previously announced transfer to North American Biologicals of the potential therapy for preventing HIV transmission from mother to unborn infant to North American Biologicals is completed, Abbott announces Nov. 4 ("The Pink Sheet" Oct. 12, T&G-5).